HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients.

Abstract
Although trihexyphenidyl has been used effectively for many years in the treatment of Parkinson's disease, little is known about its pharmacokinetics. Using a sensitive radioreceptor assay for anticholinergic drugs, we assayed trihexyphenidyl in human serum and studied its pharmacokinetics following short-term and long-term administration to patients with dystonia. Previously untreated patients had a biphasic semilogarithmic plot of serum concentration-time consisting of an initial rapid distribution phase and a later slower elimination phase. Patients on long-term treatment showed only the slower elimination phase. Elimination followed first-order kinetics and was rapid, with a half-life of 3.7 +/- 0.4 (SEM) hours. There was no relationship between half-life and peak serum level, age, duration of therapy, or etiology or severity of dystonia. Although acute anticholinergic side effects paralleled the rise and fall of serum anticholinergic levels, the response of dystonia did not.
AuthorsR E Burke, S Fahn
JournalAnnals of neurology (Ann Neurol) Vol. 18 Issue 1 Pg. 35-40 (Jul 1985) ISSN: 0364-5134 [Print] United States
PMID4037749 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Trihexyphenidyl
Topics
  • Adolescent
  • Adult
  • Child
  • Dystonia (drug therapy)
  • Female
  • Half-Life
  • Humans
  • Kinetics
  • Male
  • Radioligand Assay
  • Time Factors
  • Trihexyphenidyl (adverse effects, blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: